Literature DB >> 8562746

Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus.

M J Glesby1, R D Moore, R E Chaisson.   

Abstract

To determine the incidence and clinical manifestations of herpes zoster in a hospital-based clinic for adults infected with human immunodeficiency virus (HIV), we reviewed the records of all patients for whom zoster was diagnosed at or after their first clinic visit. Fifty-two episodes of zoster occurred in 45 patients during 1,614 person-years of follow-up (incidence, 3.2 episodes per 100 person-years). The following major complications of zoster occurred in 12 patients (27%): ocular complications (5), neurological complications (4), and chronic atypical skin lesions (5). Six patients each had postherpetic neuralgia and bacterial superinfection, which were the common minor complications of zoster. Multivariate analysis revealed that only a low CD4 cell count (< or = 200/mm3) was predictive of a major complication of zoster (OR, 13.2; 95% CI, 1.52-114; P = .019). Thus, complications of herpes zoster are common in patients with HIV infection, especially those with advanced immunosuppression.

Entities:  

Mesh:

Year:  1995        PMID: 8562746     DOI: 10.1093/clinids/21.2.370

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

1.  High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.

Authors:  Shih Hann Su; Valérie Martel-Laferrière; Annie-Claude Labbé; David R Snydman; David Kent; Michel Laverdière; Claire Béliveau; Tanya Logvinenko; Sandra Cohen; Silvy Lachance; Thomas Kiss; Jean Roy
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-25       Impact factor: 5.742

2.  Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.

Authors:  Kate Shearer; Mhairi Maskew; Toyin Ajayi; Rebecca Berhanu; Pappie Majuba; Ian Sanne; Matthew P Fox
Journal:  Int J Infect Dis       Date:  2014-03-25       Impact factor: 3.623

3.  Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.

Authors:  Kosuke Kawai; Claudia A Hawkins; Ellen Hertzmark; Joel M Francis; David Sando; Aisa N Muya; Nzovu Ulenga; Wafaie W Fawzi
Journal:  Am J Trop Med Hyg       Date:  2018-01-04       Impact factor: 2.345

4.  Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.

Authors:  Ralph P Insinga; Robbin F Itzler; James M Pellissier
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  Oesophagobronchial fistula caused by varicella zoster virus in a patient with AIDS: a unique case.

Authors:  F Moretti; C Uberti-Foppa; E Quiros-Roldan; L Fanti; F Lillo; A Lazzarin
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

6.  Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid.

Authors:  Iñigo Corral; Carmen Quereda; Antonio Antela; Vicente Pintado; José Luis Casado; Pilar Martín-Dávila; Enrique Navas; Santiago Moreno
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

7.  Impact of CCR5 Delta32/+ deletion on herpes zoster among HIV-1-infected homosexual men.

Authors:  Anneke Krol; Ruud Lensen; Jan Veenstra; Maria Prins; Hanneke Schuitemaker; Roel A Coutinho
Journal:  Eur J Epidemiol       Date:  2006-05-16       Impact factor: 8.082

8.  Herpes zoster among persons living with HIV in the current antiretroviral therapy era.

Authors:  Leah J Blank; Michael J Polydefkis; Richard D Moore; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

9.  Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.

Authors:  Ronald R White; Greg Lenhart; Puneet K Singhal; Ralph P Insinga; Robbin F Itzler; James M Pellissier; Arthur W Segraves
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Age and immune status of rhesus macaques impact simian varicella virus gene expression in sensory ganglia.

Authors:  Christine Meyer; Jesse Dewane; Amelia Kerns; Kristen Haberthur; Alex Barron; Byung Park; Ilhem Messaoudi
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.